Personalized Medicine in HER2-positive breast cancer

被引：0
|
作者：
Tsurutani, Junji [1 ]
机构：
[1] Kindai Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw459
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY-8-4
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Personalized medicine for HER2-positive breast cancer
    Wang, Zhixiang
    [J]. BREAST CANCER MANAGEMENT, 2015, 4 (05) : 237 - 240
  • [2] Personalized medicine for HER2 positive breast cancer
    Tamura, Kenji
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [3] Personalized treatment for early stage HER2-positive breast cancer
    Prat, A.
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [4] Personalized treatment approach for HER2-positive metastatic breast cancer
    Pandey, Prashant
    Chaudhary, Rishabh
    Tripathi, Devika
    Lavudi, Kousalya
    Dua, Kamal
    Weinfeld, Michael
    Lavasanifar, Afsaneh
    Rajinikanth, P. S.
    [J]. MEDICAL ONCOLOGY, 2024, 41 (11)
  • [5] HER2-positive breast cancer
    Loibl, Sibylle
    Gianni, Luca
    [J]. LANCET, 2017, 389 (10087): : 2415 - 2429
  • [6] Towards personalized treatment for early stage HER2-positive breast cancer
    Kristina Goutsouliak
    Jamunarani Veeraraghavan
    Vidyalakshmi Sethunath
    Carmine De Angelis
    C. Kent Osborne
    Mothaffar F. Rimawi
    Rachel Schiff
    [J]. Nature Reviews Clinical Oncology, 2020, 17 : 233 - 250
  • [7] Towards personalized treatment for early stage HER2-positive breast cancer
    Goutsouliak, Kristina
    Veeraraghavan, Jamunarani
    Sethunath, Vidyalakshmi
    De Angelis, Carmine
    Osborne, C. Kent
    Rimawi, Mothaffar F.
    Schiff, Rachel
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (04) : 233 - 250
  • [8] Molecular imaging with trastuzumab and pertuzumab of HER2-positive breast cancer in mice: a step towards personalized medicine
    Collin, B.
    Oudot, A.
    Vrigneaud, J-M
    Moreau, M.
    Raguin
    Duchamp
    Tizon, X.
    Denat, F.
    Varoqueaux, N.
    Brunotte, F.
    Fumoleau, P.
    [J]. CANCER RESEARCH, 2012, 72
  • [9] Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer
    Vu, Thuy
    Sliwkowski, Mark X.
    Claret, Francois X.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1846 (02): : 353 - 365
  • [10] Treatment of HER2-positive breast cancer
    Figueroa-Magalhaes, Maria Cristina
    Jelovac, Danijela
    Connolly, Roisin M.
    Wolff, Antonio C.
    [J]. BREAST, 2014, 23 (02): : 128 - 136
12345